CD93 and chronic myelogenous leukemia, BCR-ABL1 positive: This led us to question if CD93 expression represents a self-renewing population in CP-CML cells, and if it is not eliminated by TKI, could it be detected in patients who have been treated by TKI and subsequently relapse following TKI withdrawal.